18 years mitotane therapy for intractable Cushing's disease.
Kawai
S
S
Ichikawa
Y
Y
Kaburaki
J
J
Yoshida
T
T
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D003480:Cushing Syndrome / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008134:Long-Term Care; D008939:Mitotane / Q000008:administration & dosage* / Q000009:adverse effects; D009384:Paraneoplastic Endocrine Syndromes / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane